Buy this title with Catheter Ablation of Atrial Fibrillation by Etienne, MD Aliot and save $15.50 ($10.50 everyday savings + $5.00 special discount)!
Foreword: Hein J. Wellens.
Part 1 Mechanisms of VT.
1 The role of spatial dispersion of repolarization and intramural reentry in inherited and acquired sudden cardiac death syndromes: Charles Antzelevitch (Masonic Medical Research Laboratory).
2 Mechanisms of ventricular tachycardia: underlying pathological and physiological abnormalities: Jacques MT de Bakker (Academic Medical Center, Amsterdam and University Medical Center Utrecht), Harold VM van Rijen (University Medical Center Utrecht).
Part 2 Etiologies and syndromes.
3 Time-dependent gender differences in the clinical course of patients with the congenital long-QT syndrome: Ilan Goldenberg (University of Rochester Medical Center), Arthur J. Moss (University of Rochester Medical Center), Wojciech Zareba (University of Rochester Medical Center).
4 Genetics of ventricular arrhythmias: Zian H. Tseng (University of California, San Francisco), Jeffrey Olgin (University of California, San Francisco).
5 Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Rahul Jain (The Johns Hopkins University School of Medicine), Hugh Calkins (Johns Hopkins Medical Institutions).
6 Risk stratification and the implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy: Barry J. Maron (Minneapolis Heart Institute Foundation).
Part 3 Catheter and surgical ablation.
7 Mapping and ablation of ventricular tachycardia after myocardial infarction: William G. Stevenson (Brigham and Women ’s Hos pital), Usha Tedrow (Brigham and Women ’s Hospital).
8 Mapping and ablation of ventricular tachycardia in nonischemic cardiomyopathy: Henry H. Hsia (Stanford University Medical Center), Pirooz S. Mofrad (Stanford University Medical Center).
9 Mapping to define scars and isthmuses: a new paradigm for guiding ventricular tachycardia ablation: Kyoko Soejima (Keio University).
10 Ablation of idiopathic ventricular tachycardias: Nitish Badhwar (University of California, San Francisco), Melvin M. Scheinman University of California, San Francisco.
11 Ablation of ventricular fibrillation: Karen P. Phillips (Cleveland Clinic Foundation), J. David Burkhardt (Cleveland Clinic Foundation), Robert A. Schweikert (Cleveland Clinic Foundation), Walid I. Saliba (Cleveland Clinic Foundation), Andrea Natale (Cleveland Clinic Foundation).
12 Ablation of ventricular tachycardia in congenital heart disease: George F. Van Hare (Stanford University School of Medicine and UCSF).
13 Role of imaging techniques in catheter ablation of ventricular tachycardia: Mathew D. Hutchinson (University of Pennsylvania Health System), David J. Callans (University of Pennsylvania Health System).
14 Epicardial ablation of ventricular tachycardia: Mauricio Scanavacca (University of Sao Paulo Medical School), Eduardo Sosa (University of Sao Paulo Medical School).
15 Role of catheter control systems in ablation of ventricular tachycardia: Marco Perez (Stanford University), Amin Al-Ahmad (Stanford University Medical Center).
16 Current surgical techniques for ischemic ventricular tachycardia: Robert J. Moraca (Washington University School of Medicine), Marci S. Bailey (Washington University School of Medicine), Ralph J. Damiano Jr (Washington University School of Medicine).
Part 4 Epidemiology, risk stratification, and pharmacological therapy for ventricular tachycardia and sudden death .
17 Epidemiology and etiologies of sudden cardiac death: K eane K. Lee (Stanford University Medical Center), Amin Al-Ahmad (Stanford University Medical Center), Paul J.Wang (Stanford University Medical Center), Robert J. Myerburg (University of Miami).
18 Non-invasive tests for risk stratification in ischemic and non-ischemic cardiomyopathy: J. Thomas Bigger (Columbia University College of Physicians and Surgeons), Mark C. Haigney (Uniformed Services University), Robert E. Kleiger (Washington University School of Medicine).
19 Risk stratification: where we are and where do we go from here: Jeffrey J. Goldberger (Feinberg School of Medicine, Northwestern University).
20 Pharmacological management of ventricular arrhythmias: Kevin J. Makati (Tufts-New England Medical Center), Munther Homoud (Tufts-New England Medical Center), Mark S. Link (Tufts-New England Medical Center), Jonathan Weinstock (Tufts-New England Medical Center), N.A. Mark Estes III (Tufts University School of Medicine).
Part 5 Ventricular fibrillation and defibrillation.
21 The mechanisms of ventricular fibrillation: Lan S. Chen (Indiana University School of Medicine), Peng-Sheng Chen (Indiana University School of Medicine), Moshe S. Swissa (The Hebrew University).
22 Mechanisms of defibrillation: Derek J. Dosdall (University of Alabama at Birmingham), Jian Huang (University of Alabama at Birmingham), Raymond E. Ideker (University of Alabama at Birmingham).
23 Automatic external defibrillation and public access defibrillator response: Paul J. Wang (Stanford University Medical Center), Amin Al-Ahmad (Stanford University Medical Center), Robert J. Myerburg (University of Miami).
24 Advances in cardiopulmonary rescuscitation: Anurag Gupta (Stanford University Medical Center), Amin Al-Ahmad (Stanford University Medical Center).
25 Advances in implantable defibrillator therapy and technologies: Paul J. Wang (Stanford University Medical Center), Amin Al-Ahmad (Stanford University Medical Center), Henry H. Hsia (Stanford Uni versity Medical Center), Paul C. Zei (Stanford University Medical Center).
26 ICD lead extraction: when, why and how?: Bruce L. Wilkoff (Cleveland Clinic Foundation), Oussama Wazni (Cleveland Clinic Center for Cardiovascular Research).
Index